TickerFacts.

Intelligent Bio Solutions Inc. (INBS): Cost of Revenue

Annual figures by period end, from SEC filings.

$2.17M
Year ended 2026-06-30
+32.5%
3-year compound annual growth
2023-06-30: $930.2K2024-06-30: $1.69M2025-06-30: $1.81M2026-06-30: $2.17M$2.17M
2023-06-30 Cost of Revenue (USD) 2026-06-30
Period endedCost of RevenueChange YoYSource filing
2026-06-30$2.17M+19.9%2026-08-19, From 2025-07-01
2025-06-30$1.81M+7.1%2026-08-19, From 2024-07-01
2024-06-30$1.69M+81.3%2025-08-15, From 2023-07-01
2023-06-30$930.2Kn/a2024-09-18, From 2022-07-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Intelligent Bio Solutions Inc. (INBS)2026-06-30$2.17M+19.9%
Tenon Medical, Inc. (TNON)2025-12-31$1.59M+1.3%
Lucid Diagnostics Inc. (LUCD)2025-12-31$6.67M-6.0%
Picard Medical, Inc. (PMI)2025-12-31$5.14M+14.2%
IceCure Medical Ltd. (ICCM)2025-12-31$2.15M+17.0%
Nuo Therapeutics, Inc. (AURX)2025-12-31$1.10M+261.8%
OSR Health, Inc. (OSRH)2025-12-31$2.31M-14.9%
QHSLab, Inc. (USAQ)2025-12-31$880.9K+13.8%
INVO Fertility, Inc. (IVF)2025-12-31$30.6K+150.6%

Compare INBS, TNON, LUCD, PMI side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗